Megan Knight
Investor Relations Contact chez ARENA PHARMACEUTICALS
Postes actifs de Megan Knight
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARENA PHARMACEUTICALS | Investor Relations Contact | - | - |
LONGBOARD PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2021 | - |
Historique de carrière de Megan Knight
Anciens postes connus de Megan Knight
Sociétés | Poste | Début | Fin |
---|---|---|---|
SENOMYX INC. | Investor Relations Contact | - | - |
Public Communications Contact | - | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Investor Relations Contact | 3 |
Public Communications Contact | 1 |
Sectorielle
Health Technology | 3 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Senomyx, Inc.
Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Bourse
- Insiders
- Megan Knight
- Expérience